Cyrille Tupin
Chief Executive Officer at ABIONYX PHARMA
Net worth: 2 M $ as of 29/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jean-Louis Dasseux | M | 66 |
Cerenis Therapeutics, Inc.
 Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 17 years |
| Emmanuel de Fougeroux | M | - | 16 years | |
| Denis Lucquin | M | 67 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 19 years |
| Constance Keyserling | F | - | - | |
| Johan Rutger Christenson | M | 65 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 13 years |
| Christian Chavy | M | 75 | 9 years | |
| Laura Coruzzi | M | 71 | 9 years | |
| Karen Noël | F | 51 | 7 years | |
| Emmanuel Huynh | M | 54 | 5 years | |
| Mary L. Campbell | F | - |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | - |
| Alexandra Goll | M | 68 |
Cerenis Therapeutics, Inc.
Cerenis Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cerenis Therapeutics, Inc. discovers, develops and commercializes drugs for the treatment of cardiovascular and metabolic diseases. It focuses on discovery, development, and commercialization of HDL therapies. Cerenis Therapeutics is located in Ann Arbor, MI. | 13 years |
| Olivier Martinez | M | 54 | - | |
| Laurent Guerci | M | - | 1 years | |
| Renee Benghozi | M | - | 9 years | |
| Rob Scott | M | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| William F. Brinkerhoff | M | - | 6 years | |
| Catherine Moukheibir | F | 64 | 3 years | |
| Michael Davidson | M | 67 | 4 years | |
| Richard Pasternak | M | 75 | - | |
| Barbara Yanni | F | 69 | 2 years | |
| Jean-Pierre Garnier | M | 75 | - | |
| Marc Rivière | M | 65 | - | |
| Narendra D. Lalwani | M | 71 | 7 years | |
| Daniela Oniciu | M | - | 9 years | |
| Shawn Benoit | M | - | 14 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| France | 23 | 92.00% |
| United States | 5 | 20.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cyrille Tupin
- Personal Network
